Adial Pharmaceuticals, Inc.

NASDAQ (USD): Adial Pharmaceuticals, Inc. (ADIL)

Last Price

0.70

Today's Change

-0.015 (2.09%)

Day's Change

0.682 - 0.715

Trading Volume

3,363

Overview

Market Cap

4 Million

Shares Outstanding

6 Million

Avg Volume

802,713

Avg Price (50 Days)

0.73

Avg Price (200 Days)

0.95

PE Ratio

-0.25

EPS

-2.72

Earnings Announcement

12-May-2025

Previous Close

0.71

Open

0.70

Day's Range

0.6824 - 0.72

Year Range

0.58 - 3.0

Trading Volume

20,421

Price Change Highlight

1 Day Change

-4.20%

5 Day Change

-0.72%

1 Month Change

2.65%

3 Month Change

-17.47%

6 Month Change

-34.13%

Ytd Change

-35.38%

1 Year Change

-59.47%

3 Year Change

-98.04%

5 Year Change

-98.15%

10 Year Change

-99.32%

Max Change

-99.32%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment